Projects per year
- 150 - 200 out of 530 results
Search results
-
Finished
Characterising a novel driver of polycystic kidney disease
Smyth, I. (Primary Chief Investigator (PCI))
1/01/20 → 31/12/23
Project: Research
-
Defining signals that regulate intestinal stem cells during organ growth
Abud, H. (Primary Chief Investigator (PCI))
1/01/20 → 31/12/22
Project: Research
-
Redefining the nature of mitochondrial damage
McArthur, K. (Primary Chief Investigator (PCI))
1/01/20 → 31/12/23
Project: Research
-
The HIV capsid is a functional scaffold that directs bidirectional cargo transport
Boecking, T. (Primary Chief Investigator (PCI)), Jacques, D. A. (Chief Investigator (CI)), Arumugam, S. (Chief Investigator (CI)), Stear, J. (Chief Investigator (CI)) & McKenney, R. (Chief Investigator (CI))
1/01/20 → 31/12/22
Project: Research
-
Understanding the role of Dynamin in axonal repair
Neumann, B. (Primary Chief Investigator (PCI))
1/01/20 → 31/12/22
Project: Research
-
Transcriptional control of germ cell development
Pocock, R. (Primary Chief Investigator (PCI)) & Gopal, S. (Chief Investigator (CI))
National Health and Medical Research Council (NHMRC) (Australia)
1/01/20 → 31/12/22
Project: Research
-
Kidney Organoids for disease modelling Alport syndrome
Ricardo, S. (Primary Chief Investigator (PCI))
1/01/20 → 31/12/20
Project: Research
-
Tolerance of Uncertainty & Ambiguity (ToU/ToA): Identifying mechanisms for integrating this critical Future Education skill into higher education (HE
Lazarus, M. (Primary Chief Investigator (PCI)), Ziebell, A. (Chief Investigator (CI)), White, P. (Chief Investigator (CI)), Davis, E. (Chief Investigator (CI)), Parasnis, J. (Chief Investigator (CI)), Mujumdar, S. (Chief Investigator (CI)), Brock, T. (Chief Investigator (CI)) & Brand, G. (Chief Investigator (CI))
Monash University – Internal University Contribution
1/01/20 → 31/12/20
Project: Research
-
Targeting lethal prostate cancer in its infancy
Risbridger, G. (Primary Chief Investigator (PCI)), Clouston, D. (Chief Investigator (CI)), Frydenberg, M. (Chief Investigator (CI)) & Murphy, D. G. (Chief Investigator (CI))
National Health and Medical Research Council (NHMRC) (Australia)
1/01/20 → 31/12/22
Project: Research
-
Inherited Pathogenic Mutations in Prostate Cancer: The Next Generation
Taylor, R. (Primary Chief Investigator (PCI)), Thorne, H. J. (Chief Investigator (CI)), Frydenberg, M. (Chief Investigator (CI)), Risbridger, G. (Chief Investigator (CI)), Batra, J. (Chief Investigator (CI)) & Schoch, W. (Chief Investigator (CI))
Prostate Cancer Foundation of Australia
1/01/20 → 31/12/22
Project: Research
-
DNA repair: a critical quality control mechanism in the female germ line
Hutt, K. (Primary Chief Investigator (PCI))
Australian Research Council (ARC)
1/01/20 → 31/12/23
Project: Research
-
The impact of environmental toxicants on the fertility of female animals
Hutt, K. (Primary Chief Investigator (PCI)), Green, M. (Chief Investigator (CI)), Flaws, J. (Partner Investigator (PI)) & Hutt, O. E. (Partner Investigator (PI))
1/01/20 → 30/05/24
Project: Research
-
Investigating a novel factor impacting stem cell development
Pocock, R. (Primary Chief Investigator (PCI)) & Gopal, S. (Chief Investigator (CI))
1/01/20 → 31/12/23
Project: Research
-
Genetic regulation of avian sex determination
Smith, C. (Primary Chief Investigator (PCI)), Harley, V. (Chief Investigator (CI)) & Serralbo, O. (Chief Investigator (CI))
1/01/20 → 30/06/24
Project: Research
-
RNA methylation in normal and malignant blood development
Kats, L. (Primary Chief Investigator (PCI)) & Das, P. (Chief Investigator (CI))
1/01/20 → 31/12/22
Project: Research
-
Microtubule structure in nervous system repair
Neumann, B. (Primary Chief Investigator (PCI))
1/01/20 → 31/12/22
Project: Research
-
Establishing the role of apoptosis and mtDNA in lupus pathobiology
Kile, B. (Primary Chief Investigator (PCI))
1/12/19 → 30/11/21
Project: Research
-
Dissecting the regulation of nephron progenitor identity, self-renewal and commitment at a single cell level
Combes, A. (Primary Chief Investigator (PCI)), Little, M. H. (Chief Investigator (CI)) & Oshlack, A. (Chief Investigator (CI))
18/11/19 → 31/12/21
Project: Research
-
A Phase 3, Randomized, Double-blind Study to Compare the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Lenvatinib (E7080/MK-7902) Versus Pembrolizumab and Placebo as First Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma in Cisplatin-ineligible Participants Whose Tumors Express PD-L1, and in Participants Ineligible for Any Platinum-containing Chemotherapy Regardless of PD-L1 Expression (LEAP-011)
Pook, D. (Primary Chief Investigator (PCI))
24/10/19 → 25/03/20
Project: Research
-
Novel bacteria as therapeutic candidates in Inflammatory Bowel Disease
Giles, E. (Primary Chief Investigator (PCI)), Forster, S. (Chief Investigator (CI)) & Abud, H. (Chief Investigator (CI))
1/10/19 → 31/03/21
Project: Research
-
A Phase 3 Randomized Study of Cystectomy plus Perioperative Pembrolizumab versus Cystectomy Alone in Cisplatin-ineligible Participants with Muscleinvasive Bladder Cancer (KEYNOTE-905)
Pook, D. (Primary Chief Investigator (PCI))
27/09/19 → 26/09/24
Project: Research
-
A Multicenter, Open-label, Phase 1 Trial of bacTRL-IL-12 in Adult Subjects with Advanced, Treatment-Refractory Solid Tumors
Pook, D. (Primary Chief Investigator (PCI))
26/09/19 → 25/09/24
Project: Research
-
A Phase 2 Trial of Nivolumab plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer
Pook, D. (Primary Chief Investigator (PCI))
4/09/19 → 3/09/24
Project: Research
-
Resolving and translating communication within the prostate cancer microenvironment
Daly, R. (Primary Chief Investigator (PCI)), Horvath, L. G. (Chief Investigator (CI)), Taylor, R. (Chief Investigator (CI)), Timpson, P. (Associate Investigator (AI)), Cox, T. R. (Associate Investigator (AI)), Song, J. (Associate Investigator (AI)), Risbridger, G. (Associate Investigator (AI)), Kench, J. G. (Associate Investigator (AI)) & Jorgensen, C. (Associate Investigator (AI))
United States Department of Defense (DOD)
1/09/19 → 28/02/23
Project: Research
-
A real-time biomechanical study of Neanderthal anterior dentition
Fiorenza, L. (Primary Chief Investigator (PCI)), Benazzi, S. (Partner Investigator (PI)) & Sarig, R. (Partner Investigator (PI))
1/09/19 → 30/11/22
Project: Research
-
The cellular basis of branching morphogenesis during kidney development
Smyth, I. (Primary Chief Investigator (PCI)), Combes, A. (Chief Investigator (CI)), Fernandez-Gonzalez, R. (Partner Investigator (PI)) & McNeill, H. (Partner Investigator (PI))
1/08/19 → 30/07/22
Project: Research
-
A phase 3 randomised, placebo-controlled, double-blind study of Niraparib in combination with Abiraterone acetate and Prednisone versus Abiraterone acetate and Prednisone for treatment of subjects with metastatic prostate cancer [MAGNITUDE].
Pook, D. (Primary Chief Investigator (PCI)) & Baker, E. (Project Manager)
29/07/19 → 31/12/24
Project: Research
-
Genetic Diversity in the collaborative cross model recapitulates miRNA mediated neurogenesis
Xiao, Z.-C. (Primary Chief Investigator (PCI))
Apex Glory International Trading Pty Ltd
22/07/19 → 31/12/23
Project: Research
-
Investigating a new regulator of cyst development in PKD
Smyth, I. (Primary Chief Investigator (PCI)) & Cottle, D. (Chief Investigator (CI))
1/07/19 → 30/12/21
Project: Research
-
“Up-Front PSMA” Alliance: Using Theranostics Early to Eradicate Prostate Cancer and Developing Novel Strategies for PSMA-negative disease
Azad, A. (Primary Chief Investigator (PCI)), Hoffman, M. (Chief Investigator (CI)), Murphy, D. G. (Chief Investigator (CI)), Risbridger, G. (Chief Investigator (CI)), Trapani, J. A. (Chief Investigator (CI)), Williams, S. G. (Chief Investigator (CI)), Lawrentschuk, N. (Chief Investigator (CI)), Francis, R. (Chief Investigator (CI)), Vela, I. (Chief Investigator (CI)), Taylor, R. (Chief Investigator (CI)), Sandhu, S. K. (Chief Investigator (CI)), Violet, J. (Chief Investigator (CI)), Pattison, D. A. (Chief Investigator (CI)), Porter, L. (Associate Investigator (AI)), Lister, N. (Associate Investigator (AI)), Alinezhad, S. (Associate Investigator (AI)), Iravani, A. (Associate Investigator (AI)) & Zhu, J. (Associate Investigator (AI))
1/07/19 → 30/06/23
Project: Research
-
A Phase 2, single-arm study of bempegaldesleukin (NKTR-214) in combination with nivolumab in cisplatin ineligible, locally advanced or metastatic urothelial cancer patients
Pook, D. (Primary Chief Investigator (PCI))
24/06/19 → 23/06/24
Project: Research
-
A phase III randomized, double-blind, placebo-controlled trial of radium-223 dichloride in combination with abiraterone acetate and prednisone/prednisolone in the treatment of asymptomatic or mildly symptomatic chemotherapy-naïvepts with bone predominant metastatic castration-resistant prostate cancer (CRPC)
Pook, D. (Primary Chief Investigator (PCI))
20/06/19 → 19/06/24
Project: Research
-
How do neurons maintain their fate?
Harvey, K. (Primary Chief Investigator (PCI)), Schroeder, J. (Chief Investigator (CI)) & Cheng, L. (Chief Investigator (CI))
17/06/19 → 16/06/22
Project: Research
-
Intraocular delivery of Avastin using topical ultrasound (proof of principle)
De Veer, M. (Primary Chief Investigator (PCI)), Paterson, B. (Chief Investigator (CI)) & Sepehrizadeh, T. (Chief Investigator (CI))
1/06/19 → 1/01/20
Project: Research
-
A phase 1b, open label, multicenter study evaluating the safety and efficacy of ipatasertib in combination with rucaparib in patients with advanced breast, ovarian or prostate cancer [BO40933].
Pook, D. (Primary Chief Investigator (PCI)) & Baker, E. (Project Manager)
24/05/19 → 31/12/24
Project: Research
-
A Phase Iii, Multicenter, Randomized Study Of Atezolizumab (Anti−Pdl1 Antibody) In Combination With Enzalutamide Versus Enzalutamide Alone In Patients With Metastatic Castrationresistant Prostate Cancer After Failure Of An Androgen Synthesis Inhibitor And Failure Of, Ineligibility For, Or Refusal Of A Taxane Regimen
Pook, D. (Primary Chief Investigator (PCI))
20/05/19 → 19/05/24
Project: Research
-
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial Testing Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative To Placebo Plus Abiraterone Plus Prednisone/Prednisolone In Adult Male Patients With Asymptomatic Or Mildly Symptomatic, Previously Untreated, Metastatic Castrate-Resistant Prostate Cancer
Pook, D. (Primary Chief Investigator (PCI))
6/05/19 → 5/05/24
Project: Research
-
Use of brain organoids and artificial intelligence for understanding dementia
Jagadish, C. (Primary Chief Investigator (PCI)), Gautam, V. (Chief Investigator (CI)), Halgamuge, S. (Chief Investigator (CI)), Pébay, A. (Chief Investigator (CI)), Hernandez, D. (Chief Investigator (CI)), Grubman, A. (Chief Investigator (CI)), Dottori, M. (Chief Investigator (CI)) & Ooi, L. (Chief Investigator (CI))
1/05/19 → 1/05/22
Project: Research
-
A Phase II trial of single agent cabozantinib in patients with locally advanced or metastatic non-clear cell renal cell carcinoma post immunotherapy or who are unsuitable for immunotherapy
Pook, D. (Primary Chief Investigator (PCI))
30/04/19 → 29/04/24
Project: Research
-
Denosumab and Pembrolizumab in Renal Cell Carcinoma: A Phase II Trial
Pook, D. (Primary Chief Investigator (PCI))
25/03/19 → 24/03/24
Project: Research
-
Evo-Devo down under; Genetic regulation of wing reduction in the emu
Smith, C. (Primary Chief Investigator (PCI)) & Tarbin, C. (Partner Investigator (PI))
2/03/19 → 1/03/22
Project: Research
-
Improve access to novel treatments and trials for advanced prostate cancer patients: Precision Oncology Program
Iddawela, M. (Primary Chief Investigator (PCI)), Risbridger, G. (Chief Investigator (CI)) & Shackleton, M. (Chief Investigator (CI))
1/03/19 → 29/02/20
Project: Research
-
New combination therapies for castration-resistant prostate cancer
Lawrence, M. (Primary Chief Investigator (PCI)), Risbridger, G. (Associate Investigator (AI)), Azad, A. (Associate Investigator (AI)) & Taylor, R. (Associate Investigator (AI))
15/02/19 → 14/02/23
Project: Research
-
Marsupial development on a megafaunal scale – evolutionary trends in the life history of macropods
Evans, A. (Primary Chief Investigator (PCI)), Parker, W. (Chief Investigator (CI)), de Jonge, M. (Chief Investigator (CI)) & Adams, J. (Chief Investigator (CI))
14/02/19 → 17/02/19
Project: Research
-
Elucidation of tumour cell plasticity mechanisms associated to treatment in metastatic prostate cancer
Marin-Aguilera, M. (Primary Chief Investigator (PCI)) & Risbridger, G. (Supervisor)
12/01/19 → 21/01/21
Project: Research
-
Giving prostate cancer enough rope with supraphysiologic testosterone
Lawrence, M. (Primary Chief Investigator (PCI)), Risbridger, G. (Chief Investigator (CI)) & Joshua, A. M. (Chief Investigator (CI))
National Health and Medical Research Council (NHMRC) (Australia)
1/01/19 → 31/12/21
Project: Research
-
Enhancing the anti-fibrotic and regenerative capacity of bone marrow-derived stem cells
Samuel, C. (Primary Chief Investigator (PCI)), Ricardo, S. (Chief Investigator (CI)), Widdop, R. (Chief Investigator (CI)) & Kerr, P. (Chief Investigator (CI))
1/01/19 → 31/12/21
Project: Research
-
A therapy to restore ageing defects in egg and sperm
Robker, R. (Primary Chief Investigator (PCI)) & Carroll, J. (Chief Investigator (CI))
1/01/19 → 31/12/22
Project: Research
-
Assessing and comparing function of brain organoids from persons with dementia and normal controls.
Jagadish, C. (Primary Chief Investigator (PCI)), Dottori, M. (Chief Investigator (CI)), Gautam, V. (Chief Investigator (CI)), Grubman, A. (Chief Investigator (CI)), Hernandez, D. (Chief Investigator (CI)), Ooi, L. (Chief Investigator (CI)) & Pébay, A. (Chief Investigator (CI))
1/01/19 → 31/12/19
Project: Research
-
Dissecting TAF5L and TAF6L functions in embryonic stem cells, reprogramming and neurodevelopment
Das, P. (Primary Chief Investigator (PCI))
National Health and Medical Research Council (NHMRC) (Australia)
1/01/19 → 31/12/21
Project: Research